Evidence map›Paper›PMID 26113514›Full record

ArticleEpidemiology and infection2016

A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone.

L Valinsky, J Jaffe, N Keller, C Block, N Abramson, C Stein-Zamir

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

L ValinskyGovernment Central Laboratories,Ministry of Health,Jerusalem,Israel.
J JaffeGovernment Central Laboratories,Ministry of Health,Jerusalem,Israel.
N KellerNational Reference Center for Meningococci,Microbiology Laboratory,Sheba Medical Center,Ministry of Health,Israel.
C BlockDepartment of Clinical Microbiology and Infectious Diseases,Hadassah-Hebrew University Medical Center,Jerusalem,Israel.
N AbramsonJerusalem District Health Office,Ministry of Health,Israel.
C Stein-ZamirJerusalem District Health Office,Ministry of Health,Israel.
Israel Ministry of Health · ILHadassah Medical Center · ILSheba Medical Center · IL

Funding

Wellcome Trust
6 · The paper itself

Abstract

The incidence of invasive infections due to Neisseria meningitidis in Israel is about 1/100 000 population annually. Three cases of meningococcal meningitis were reported in employees at a single plant; the first case appeared in March 2013 and the second and third cases appeared in December, almost 9 months later. N. meningitidis serogroup B was isolated from cerebrospinal fluid samples. Multilocus sequence typing assigned the three meningococcal isolates to ST10418, a new sequence type and a member of the ST32 clonal complex. The clonality was confirmed by performance of pulsed-field gel electrophoresis. Post-exposure antibiotic prophylaxis was administered to close contacts of the first case. Upon the diagnosis of the additional two cases, post-exposure prophylaxis was administered to all the plant employees. This report demonstrates the importance of combining public health measures and advanced laboratory studies to confirm clonality and to prevent further disease spread in a closed setting.

Indexed as

Post-Exposure ProphylaxisAdultAnti-Bacterial AgentsCluster AnalysisElectrophoresis, Gel, Pulsed-FieldHumansIsraelMaleMeningitis, MeningococcalMiddle AgedMultilocus Sequence TypingNeisseria meningitidis, Serogroup BAnti-Bacterial AgentsClusterinvasive meningococcal diseasemolecular epidemiologyNeisseria meningitidis

Identifiers

PMID26113514
PMCPMC9507310
OpenAlexW1883771294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.